8-K current report · filed Aug 6, 2026

Arteris, Inc. (AIP) 8-K Current Report: August 6, 2026

Item 5.02Item 7.01Item EX-99.1AIP overview

Short answer

Arteris, Inc. (AIP) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Saurabh Sinha appointed CFO, principal financial officer and principal accounting officer effective September 8, 2026.

Arteris, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Saurabh Sinha appointed CFO, principal financial officer and principal accounting officer effective September 8, 2026
  • Prior CFO experience at Aeva Technologies, JUUL Labs and InvenSense, strengthening finance leadership
  • Annual salary $440,000 with target bonus opportunity equal to 60% of base salary
  • Equity package totals $5,700,000 target value across 2026 PSU, RSUs and 2027 PSU
  • 2026 PSU requires $200,000,000 trailing revenue and $65 average share price by December 31, 2031

Item 7.01 · Regulation FD Disclosure

  • August 6, 2026 press release announced a previously described leadership change
  • Exhibit 99.1 contains the substantive announcement and details relevant to succession and execution risk

Item EX-99.1 · Exhibit EX-99.1

  • CFO transition effective September 8, 2026, with Saurabh Sinha succeeding retiring CFO Nick Hawkins
  • Hawkins to advise through February 2027, reducing near-term execution and transition risk
  • Sinha brings more than 25 years of financial leadership, including CFO experience at public technology company Aeva Technologies
  • Leadership change supports Arteris’s scaling, governance and capital-markets needs amid AI-driven semiconductor demand

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Arteris, Inc. 8-K filings

Get the next AIP 8-K as it lands

Follow AIP for push alerts, or ask the research agent what this filing means.